Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Cognition Therapeutics, Inc. (CGTX) had Weighted-Average Shares Outstanding (Diluted) of 77.95M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-4.93M |
|
-- |
|
-- |
|
$6.38M |
|
$-6.38M |
|
$1.45M |
|
$-4.93M |
|
$-4.93M |
|
$-4.93M |
|
$-4.93M |
|
$-4.93M |
|
$-4.93M |
|
$-6.38M |
|
$-6.31M |
|
77.95M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
77.95M |
$-0.06 |
|
$-0.06 |
|
| Balance Sheet Financials | |
$42.88M |
|
$0.16M |
|
$0.51M |
|
$43.40M |
|
$6.65M |
|
-- |
|
$0.21M |
|
$6.87M |
|
$36.53M |
|
$36.53M |
|
$36.53M |
|
88.27M |
|
| Cash Flow Statement Financials | |
$-21.15M |
|
-- |
|
$35.97M |
|
$25.01M |
|
$39.82M |
|
$14.81M |
|
$1.73M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.44 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-21.15M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.50% |
|
-13.50% |
|
-11.36% |
|
-13.50% |
|
$0.41 |
|
$-0.27 |
|
$-0.27 |
|